These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10327039)

  • 1. Modulation of 9-nitrocamptothecin-induced apoptosis by hyperthermia in human leukemia HL-60 cells.
    Pantazis P; Chatterjee D; Han Z; Wyche J
    Anticancer Drugs; 1999 Mar; 10(3):317-22. PubMed ID: 10327039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schedule-dependent efficiency of thermochemotherapy in vitro with etoposide and heating at 43 degrees C.
    Pantazis P; Han Z; Wyche J
    Anticancer Res; 1999; 19(2A):995-8. PubMed ID: 10368644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of camptothecin-resistant human leukemia cells and tumors to anticancer drugs with diverse mechanisms of action.
    Pantazis P; Vardeman D; Mendoza J; Early J; Kozielski A; DeJesus A; Giovanella B
    Leuk Res; 1995 Jan; 19(1):43-55. PubMed ID: 7837817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial characterization of human leukemia U-937 cell sublines resistant to 9-nitrocamptothecin.
    Pantazis P; Mendoza JT; DeJesus A; Rubin E; Kufe D; Giovanella BC
    Eur J Haematol; 1994 Sep; 53(3):135-44. PubMed ID: 7925856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Camptothecin and 9-nitrocamptothecin (9NC) as anti-cancer, anti-HIV and cell-differentiation agents. Development of resistance, enhancement of 9NC-induced activities and combination treatments in cell and animal models.
    Pantazis P; Han Z; Balan K; Wang Y; Wyche JH
    Anticancer Res; 2003; 23(5A):3623-38. PubMed ID: 14666658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 9-Nitrocamptothecin inhibits tumor recrosis factor-mediated activation of human immunodeficiency virus type 1 and enhances apoptosis in a latently infected T cell clone.
    Moulton S; Pantazis P; Epstein JS; Sadaie MR
    AIDS Res Hum Retroviruses; 1998 Jan; 14(1):39-49. PubMed ID: 9453250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).
    Chatterjee D; Schmitz I; Krueger A; Yeung K; Kirchhoff S; Krammer PH; Peter ME; Wyche JH; Pantazis P
    Cancer Res; 2001 Oct; 61(19):7148-54. PubMed ID: 11585748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship of alkyl 9-nitrocamptothecin esters.
    Cao ZS; Pantazis P; Mendoza J; Early J; Kozielski A; Harris N; Giovanella B
    Acta Pharmacol Sin; 2003 Feb; 24(2):109-19. PubMed ID: 12546717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 9-Nitro-camptothecin delays growth of U-937 leukemia tumors in nude mice and is cytotoxic or cytostatic for human myelomonocytic leukemia lines in vitro.
    Pantazis P; Mendoza JT; Early JA; Kozielski AJ; Natelson EA; Giovanella BC
    Eur J Haematol; 1993 Feb; 50(2):81-9. PubMed ID: 8440362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propionate and butyrate esters of camptothecin and 9-nitrocamptothecin as antileukemia prodrugs in vitro.
    Han Z; Cao Z; Chatterjee D; Wyche J; Pantazis P
    Eur J Haematol; 1999 Apr; 62(4):246-55. PubMed ID: 10227458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of 9-nitrocamptothecin-triggered apoptosis in DU-145 human prostate cancer cells by ectopic expression of 14-3-3zeta.
    Chatterjee D; Goldman M; Braastad CD; Darnowski J; Wyche JH; Pantazis P; Goodglick L
    Int J Oncol; 2004 Aug; 25(2):503-9. PubMed ID: 15254750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 9-nitrocamptothecin selectively inhibits human immunodeficiency virus type 1 replication in freshly infected parental but not 9-nitrocamptothecin-resistant U937 monocytoid cells.
    Sadaie MR; Doniger J; Hung CL; Pantazis P
    AIDS Res Hum Retroviruses; 1999 Feb; 15(3):239-45. PubMed ID: 10052754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of human malignant melanoma cells that escape apoptosis after treatment with 9-nitrocamptothecin in vitro.
    Pantazis P; Chatterjee D; Han Z; Wyche J
    Neoplasia; 1999 Aug; 1(3):231-40. PubMed ID: 10935478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of apoptosis in malignant and camptothecin-resistant human cells.
    Chatterjee D; Wyche JH; Pantazis P
    Ann N Y Acad Sci; 1996 Dec; 803():143-56. PubMed ID: 8993507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic efficacy of 9-nitrocamptothecin in the treatment of human malignant melanoma cells in vitro.
    Pantazis P; Early JA; Mendoza JT; DeJesus AR; Giovanella BC
    Cancer Res; 1994 Feb; 54(3):771-6. PubMed ID: 8306340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 9-Nitrocamptothecin is an effective drug for the treatment of human lung tumors: comparison of in vitro and in vivo studies.
    Han Z; Wyche JH; Sands H; Pantazis P
    Anticancer Res; 2001; 21(3B):1823-7. PubMed ID: 11497265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of senescent cell-derived inhibitor of DNA synthesis gene, SDI1, in hepatoblastoma (HepG2) cells arrested in the G2-phase of the cell cycle by 9-nitrocamptothecin.
    Khaoustov VI; Ozer A; Smith JR; Noda A; Mearns M; Krishnan B; Slagle BL; Yoffe B
    Lab Invest; 1995 Jul; 73(1):118-27. PubMed ID: 7603034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of human breast carcinoma tumors in immunodeficient mice treated with 9-nitrocamptothecin: differential response of nontumorigenic and tumorigenic human breast cells in vitro.
    Pantazis P; Early JA; Kozielski AJ; Mendoza JT; Hinz HR; Giovanella BC
    Cancer Res; 1993 Apr; 53(7):1577-82. PubMed ID: 8453626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of human prostate tumor xenografts in nude mice and response to 9-nitrocamptothecin in vivo and in vitro does not correlate with the expression of various apoptosis-regulating proteins.
    Pantazis P; Chatterjee D; Wyche J; DeJesus A; Early J; Plaschke S; Giovanella B
    J Exp Ther Oncol; 1996 Sep; 1(5):322-33. PubMed ID: 9414421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of resistance to 9-nitro-camptothecin by human leukemia U-937 cells in vitro correlates with altered sensitivities to several anticancer drugs.
    Pantazis P; Mendoza J; DeJesus A; Early J; Shaw M; Giovanella BC
    Anticancer Drugs; 1994 Aug; 5(4):473-9. PubMed ID: 7949254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.